Oral etoposide in the treatment of hormone-refractory prostate cancer
- 1 July 1994
- Vol. 74 (1) , 100-103
- https://doi.org/10.1002/1097-0142(19940701)74:1<100::aid-cncr2820740118>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group studyCancer, 1993
- Cytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer, 1993
- Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapyCancer, 1992
- A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.Journal of Clinical Oncology, 1985
- Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostateCancer, 1979